AnalystsSean Lee
Sean Lee's Stock Forecasts

Analyst Ranking
Top 6%
#290 out of 5077 analysts
Average Return
+35.92%
Win Rate
37%37 out of 101
Risk vs Reward
Poor
Good

Sean Lee's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Senseonics Holdings IncSENS
+1,316.16%$0.50$7.01
2025-07-08 -
2025-10-24
Buy
Senseonics Holdings IncSENS
+1,222.64%$0.53$7.01
2025-06-02 -
2025-10-24
Buy
Monopar TherapeuticsMNPR
+1,072.87%$3.36$39.42
2024-05-10 -
2025-05-09
Buy
Monopar TherapeuticsMNPR
+389.62%$16.66$81.57
2024-11-11 -
2025-10-24
Buy
Alphatec Holdings IncATEC
+346.70%$3.94$17.60
2020-04-09 -
2021-04-09
Buy

Sean Lee Analyst Color

Get additional color on Sean Lee's coverage of popular stocks

Sean Lee's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Novavax IncNVAX
2Buy$11.00+29.11%Maintains
4 days ago
Dogwood Therapeutics IncDWTX
5Buy$12.00+104.08%Maintains
a month ago
Akari Therapeutics PLCAKTX
2Buy$1.60+116.22%Reiterates
2 months ago
Casi Pharmaceuticals IncCASI
10Buy$4.00+143.90%Reiterates
2 months ago
Myomo IncMYO
6Buy$5.00+350.45%Maintains
2 months ago
Kazia Therapeutics LtdKZIA
5Buy$13.00+86.25%Maintains
4 months ago
Senseonics Holdings IncSENS
2Buy$1.40-80.03%Maintains
4 months ago
Plus Therapeutics IncPSTV
12Buy$3.00+383.87%Maintains
4 months ago
Cytosorbents CorpCTSO
13Hold$1.00+17.65%Reiterates
5 months ago
Verastem IncVSTM
14Buy$14.00+76.10%Maintains
6 months ago
Alphatec Holdings IncATEC
11Buy$20.00+24.15%Reiterates
6 months ago
Monopar TherapeuticsMNPR
9Buy$40.00-50.96%Reiterates
7 months ago
Corvus Pharmaceuticals IncCRVS
3Buy$11.00+49.66%Reiterates
7 months ago
Gritstone Bio IncGRTSQ
12Hold$0.50N/ADowngrades
a year ago
Thermogenesis Holdings IncTHMO
6Buy$5.00N/AReiterates
2 years ago
Aceragen IncACGN
1HoldN/AN/ADowngrades
5 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.